OverviewSuggest Edit

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a postemergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The Company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases.

... Show more
TypePublic
Founded2006
HQDavis, US
Websitemarronebioinnovations.com
Employee Ratings2.7

Latest Updates

Employees (est.) (Feb 2019)103
Job Openings8
Revenue (FY, 2017)$18.2 M(+30%)
Share Price (Feb 2019)$1.6 (+7%)

Key People/Management at Marrone Bio Innovations

Pam Marrone

Pam Marrone

Founder and CEO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs
Show more

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave
Show all (2)
Report incorrect company information

Marrone Bio Innovations Financials and Metrics

Marrone Bio Innovations Revenue

Marrone Bio Innovations's revenue was reported to be $18.17 m in FY, 2017
USD

Revenue (Q3, 2018)

5.4m

Net income (Q3, 2018)

(4.4m)

EBIT (Q3, 2018)

(4.2m)

Market capitalization (15-Feb-2019)

174.9m

Closing stock price (15-Feb-2019)

1.6

Cash (30-Sep-2018)

20.5m

EV

156.1m
Marrone Bio Innovations's current market capitalization is $174.9 m.
Annual
USDFY, 2013Y, 2014FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

14.5m1.1m9.1m9.8m14.0m18.2m

Revenue growth, %

(92%)793%43%

General and administrative expense

15.0m29.0m26.5m18.5m19.8m

Operating expense total

32.8m48.2m40.0m28.2m30.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

1.3m2.8m3.6m2.1m3.4m2.5m2.7m5.0m3.6m4.2m6.5m4.2m4.3m5.8m5.4m

General and administrative expense

4.5m6.3m6.0m7.9m7.4m5.3m5.5m4.5m3.8m5.3m5.1m5.2m5.0m4.7m4.1m

R&D expense

4.5m

Operating expense total

8.9m10.6m10.3m11.3m10.7m8.8m7.9m6.8m6.4m7.8m7.9m8.3m7.6m7.2m6.8m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

24.5m35.3m19.8m9.6m786.0k

Accounts Receivable

6.2m1.8m2.3m3.6m3.8m

Inventories

11.7m12.6m9.1m8.5m9.8m

Current Assets

58.7m54.7m36.0m26.9m19.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(28.5m)(51.7m)(43.7m)(31.1m)(30.9m)

Depreciation and Amortization

976.0k2.6m3.5m2.2m2.0m

Inventories

(6.8m)73.0k3.6m582.0k(1.3m)

Accounts Payable

1.7m1.7m(3.5m)(588.0k)2.3m
USDY, 2018

EV/EBIT

-37.6 x

EV/CFO

-9.3 x

Financial Leverage

2.8 x
Show all financial metrics
Report incorrect company information

Marrone Bio Innovations Online and Social Media Presence

Embed Graph
Report incorrect company information

Marrone Bio Innovations News and Updates

Marrone Bio Innovations granted claims for MBI-110 bacterium, active ingredient in Amplitude™ and Stargus® biofungicides

DAVIS, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, has received a notice of allowance from the U.S. Patent and Trademark Office for claims covering MBI-110 bacterium as ant…

Marrone Bio Innovations to Host Virtual Roadshow Webinar on February 12th at 8:30 a.m. Pacific Time

DAVIS, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), an international leader in smart biopesticide and plant health solutions, today announced that it will host a virtual roadshow webinar on February 12, 2019 at 8:30 a.m. Pacific t…

Marrone Bio Innovations CEO Pam Marrone to receive ‘Sustie’ award for her contributions to sustainable agriculture

PACIFIC GROVE, Calif., Jan. 25, 2019 (GLOBE NEWSWIRE) -- 39th Annual EcoFarm Conference -- Dr. Pam Marrone, founder and CEO of Marrone Bio Innovations Inc. (NASDAQ: MBII), will be honored by the Ecological Farming Association tonight at the EcoFarm Awards Dinner Banquet. She will be presented with…

Two Marrone Bio Innovations products, MBI-110 Biofungicide and Haven Sunprotectant, approved for sale in Canada

DAVIS, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, today announced that two of its products have been approved for sale in Canada by the appropriate government agencies. MBI-1…

Marrone Bio Innovations Appoints Matthew O. Brecht, Ph.D. as New Cannabis Key Account Manager

DAVIS, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Matthew O. Brecht, Ph.D. has joined as Key Account Manager for the cannabis agricultural marke…

Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform

DAVIS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), launches TerraConnect, a new global biological soil applied and seed treatment platform delivering growers high performance products as well as a broad range of valuable tools to improve and protec…
Show more
Report incorrect company information

Marrone Bio Innovations Blogs

Marrone Bio Innovations’ almond bloom solutions increase farmer ROI and support new Almond Orchard 2025 Goals

DAVIS, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of biological crop protection and plant health solutions, is offering a pair of products - Haven® for Plant Health and Regalia® Biofungicide - to serve California almond growers as…

Restoring Soil Health Takes Time

By Darrell Smith | Farm Journal, Conservation and Machinery | Article Link After rapid gains from vertical tillage, pH and fertility, the improvement pace slows down Another year of results from a long-term comparison of healthy and unhealthy soil in central Illinois confirms the trend: Improvements…

Investor Presentation (February 2019)

Investor Presentation

Prevent Fire Blight with Biological Controls

Growing Produce | Article Link | January 17, 2019 | Kathie Zipp Regalia from Marrone Bio Innovations Regalia biofungicide stimulates the plant’s innate ability to fight diseases. It is recommended for use in specialty crops, while Regalia Rx is targeted to broad-acre row crops. Regalia can be used a…

Marrone Bio Innovations CEO Pam Marrone to receive ‘Sustie’ award for her contributions to sustainable agriculture

PACIFIC GROVE, Calif., Jan. 25, 2019 (GLOBE NEWSWIRE) -- 39th Annual EcoFarm Conference -- Dr. Pam Marrone, founder and CEO of Marrone Bio Innovations Inc. (NASDAQ: MBII), will be honored by the Ecological Farming Association tonight at the EcoFarm Awards Dinner Banquet. She will be presented with t…

National Securities Initiates Coverage of MBII

Download the report: MBII Initiation, National Securities January 23, 2019 Marrone Bio Innovations BUY (MBII, $1.31) Bucking The Trend: Buy Opportunity For High Growth Business In Sluggish Agriculture Market; Initiating Coverage Of Marrone Bio Innovations With A BUY Rating And $2.50 Price Target
Show more

Marrone Bio Innovations Company Life and Culture

Report incorrect company information

Marrone Bio Innovations Frequently Asked Questions

  • When was Marrone Bio Innovations founded?

    Marrone Bio Innovations was founded in 2006.

  • Who are Marrone Bio Innovations key executives?

    Marrone Bio Innovations's key executives are Pam Marrone and Keith Pitts.

  • How many employees does Marrone Bio Innovations have?

    Marrone Bio Innovations has 103 employees.

  • What is Marrone Bio Innovations revenue?

    Latest Marrone Bio Innovations annual revenue is $18.2 m.

  • What is Marrone Bio Innovations revenue per employee?

    Latest Marrone Bio Innovations revenue per employee is $176.4 k.

  • Who are Marrone Bio Innovations competitors?

    Competitors of Marrone Bio Innovations include Calyxt, B.R.A.I.N. Biotechnology Research and Information Network and Ceres.

  • Where is Marrone Bio Innovations headquarters?

    Marrone Bio Innovations headquarters is located at 2121 Second St., Davis.

  • Where are Marrone Bio Innovations offices?

    Marrone Bio Innovations has an office in Davis.

  • How many offices does Marrone Bio Innovations have?

    Marrone Bio Innovations has 2 offices.